The global Pimozide market size was valued at US$ 11.1 million in 2024 and is forecast to a readjusted size of USD 10.5 million by 2031 with a CAGR of -0.9% during review period.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Global Pimozide key players include Teva, Par Pharmaceutical, Johnson & Johnson, etc. Global top three manufacturers hold a share about 80%.
North America is the largest market, with a share about 40%, followed by Europe and South America, both have a share about 45 percent.
In terms of product, 2Mg is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospitals, followed by Drugstores, etc.
This report is a detailed and comprehensive analysis for global Pimozide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pimozide market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pimozide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pimozide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pimozide market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pimozide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pimozide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Par Pharmaceutical, Johnson & Johnson, Eumedica, Pharmascience, Domina Pharmaceuticals, Aa Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Pimozide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
1Mg
2Mg
4Mg
麻豆原创 segment by Application
Hospitals
Drugstores
Others
Major players covered
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pimozide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pimozide, with price, sales quantity, revenue, and global market share of Pimozide from 2020 to 2025.
Chapter 3, the Pimozide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pimozide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pimozide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pimozide.
Chapter 14 and 15, to describe Pimozide sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Pimozide Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 1Mg
1.3.3 2Mg
1.3.4 4Mg
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Pimozide Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Pimozide 麻豆原创 Size & Forecast
1.5.1 Global Pimozide Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pimozide Sales Quantity (2020-2031)
1.5.3 Global Pimozide Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Pimozide Product and Services
2.1.4 Teva Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Teva Recent Developments/Updates
2.2 Par Pharmaceutical
2.2.1 Par Pharmaceutical Details
2.2.2 Par Pharmaceutical Major Business
2.2.3 Par Pharmaceutical Pimozide Product and Services
2.2.4 Par Pharmaceutical Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Par Pharmaceutical Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Pimozide Product and Services
2.3.4 Johnson & Johnson Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Eumedica
2.4.1 Eumedica Details
2.4.2 Eumedica Major Business
2.4.3 Eumedica Pimozide Product and Services
2.4.4 Eumedica Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Eumedica Recent Developments/Updates
2.5 Pharmascience
2.5.1 Pharmascience Details
2.5.2 Pharmascience Major Business
2.5.3 Pharmascience Pimozide Product and Services
2.5.4 Pharmascience Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Pharmascience Recent Developments/Updates
2.6 Domina Pharmaceuticals
2.6.1 Domina Pharmaceuticals Details
2.6.2 Domina Pharmaceuticals Major Business
2.6.3 Domina Pharmaceuticals Pimozide Product and Services
2.6.4 Domina Pharmaceuticals Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Domina Pharmaceuticals Recent Developments/Updates
2.7 Aa Pharma
2.7.1 Aa Pharma Details
2.7.2 Aa Pharma Major Business
2.7.3 Aa Pharma Pimozide Product and Services
2.7.4 Aa Pharma Pimozide Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Aa Pharma Recent Developments/Updates
3 Competitive Environment: Pimozide by Manufacturer
3.1 Global Pimozide Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pimozide Revenue by Manufacturer (2020-2025)
3.3 Global Pimozide Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Pimozide by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Pimozide Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Pimozide Manufacturer 麻豆原创 Share in 2024
3.5 Pimozide 麻豆原创: Overall Company Footprint Analysis
3.5.1 Pimozide 麻豆原创: Region Footprint
3.5.2 Pimozide 麻豆原创: Company Product Type Footprint
3.5.3 Pimozide 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pimozide 麻豆原创 Size by Region
4.1.1 Global Pimozide Sales Quantity by Region (2020-2031)
4.1.2 Global Pimozide Consumption Value by Region (2020-2031)
4.1.3 Global Pimozide Average Price by Region (2020-2031)
4.2 North America Pimozide Consumption Value (2020-2031)
4.3 Europe Pimozide Consumption Value (2020-2031)
4.4 Asia-Pacific Pimozide Consumption Value (2020-2031)
4.5 South America Pimozide Consumption Value (2020-2031)
4.6 Middle East & Africa Pimozide Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Pimozide Sales Quantity by Type (2020-2031)
5.2 Global Pimozide Consumption Value by Type (2020-2031)
5.3 Global Pimozide Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Pimozide Sales Quantity by Application (2020-2031)
6.2 Global Pimozide Consumption Value by Application (2020-2031)
6.3 Global Pimozide Average Price by Application (2020-2031)
7 North America
7.1 North America Pimozide Sales Quantity by Type (2020-2031)
7.2 North America Pimozide Sales Quantity by Application (2020-2031)
7.3 North America Pimozide 麻豆原创 Size by Country
7.3.1 North America Pimozide Sales Quantity by Country (2020-2031)
7.3.2 North America Pimozide Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Pimozide Sales Quantity by Type (2020-2031)
8.2 Europe Pimozide Sales Quantity by Application (2020-2031)
8.3 Europe Pimozide 麻豆原创 Size by Country
8.3.1 Europe Pimozide Sales Quantity by Country (2020-2031)
8.3.2 Europe Pimozide Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Pimozide Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pimozide Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pimozide 麻豆原创 Size by Region
9.3.1 Asia-Pacific Pimozide Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pimozide Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Pimozide Sales Quantity by Type (2020-2031)
10.2 South America Pimozide Sales Quantity by Application (2020-2031)
10.3 South America Pimozide 麻豆原创 Size by Country
10.3.1 South America Pimozide Sales Quantity by Country (2020-2031)
10.3.2 South America Pimozide Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Pimozide Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pimozide Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pimozide 麻豆原创 Size by Country
11.3.1 Middle East & Africa Pimozide Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pimozide Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Pimozide 麻豆原创 Drivers
12.2 Pimozide 麻豆原创 Restraints
12.3 Pimozide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Pimozide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pimozide
13.3 Pimozide Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pimozide Typical Distributors
14.3 Pimozide Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
听
听
*If Applicable.
